JESSICA RUNQUIST: Open Payments
NPI 1124557376 · SWANSEA, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 44 payments from 13 companies in 2025. Trend: 2023 $2,022 · 2024 $1,278 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 3 | $258 |
| ABBVIE INC. | 21 | $213 |
| Galderma Laboratories, L.P. | 2 | $166 |
| E.R. Squibb & Sons, L.L.C. | 4 | $99 |
| Janssen Biotech, Inc. | 3 | $99 |
| PFIZER INC. | 3 | $69 |
| UCB, Inc. | 2 | $44 |
| LEO Pharma Inc. | 1 | $24 |
| LNHC, Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
Products named: Zoryve, SKYRIZI, NEMLUVIO, Sotyktu, TREMFYA, CIBINQO, Bimzelx, RINVOQ.
Industry payments across MA — which companies pay providers there.
